AU2002321229A1 - Method for identifying anti-inflammatory drugs - Google Patents

Method for identifying anti-inflammatory drugs

Info

Publication number
AU2002321229A1
AU2002321229A1 AU2002321229A AU2002321229A AU2002321229A1 AU 2002321229 A1 AU2002321229 A1 AU 2002321229A1 AU 2002321229 A AU2002321229 A AU 2002321229A AU 2002321229 A AU2002321229 A AU 2002321229A AU 2002321229 A1 AU2002321229 A1 AU 2002321229A1
Authority
AU
Australia
Prior art keywords
inflammatory drugs
identifying anti
identifying
inflammatory
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002321229A
Inventor
Birgit Jung
Norbert Kraut
Stefan Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Publication of AU2002321229A1 publication Critical patent/AU2002321229A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002321229A 2001-08-06 2002-07-17 Method for identifying anti-inflammatory drugs Abandoned AU2002321229A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01119003.0 2001-08-06
EP01119003 2001-08-06
PCT/EP2002/007937 WO2003014745A2 (en) 2001-08-06 2002-07-17 Method for identifying anti-inflammatory drugs

Publications (1)

Publication Number Publication Date
AU2002321229A1 true AU2002321229A1 (en) 2003-02-24

Family

ID=8178260

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002321229A Abandoned AU2002321229A1 (en) 2001-08-06 2002-07-17 Method for identifying anti-inflammatory drugs

Country Status (6)

Country Link
EP (1) EP1425587A2 (en)
JP (1) JP2005503787A (en)
AU (1) AU2002321229A1 (en)
CA (1) CA2453913A1 (en)
MX (1) MXPA04001128A (en)
WO (1) WO2003014745A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005074969A2 (en) * 2004-02-07 2005-08-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a1 (nr4a1)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024471A1 (en) * 1997-11-10 1999-05-20 The Research Foundation Of State University Of New York Opiate, cannabinoid, and estrogen receptors
TR200103002T2 (en) * 1999-03-11 2002-03-21 Nuclear Receptor Research Limited New ligands for PPAR n kleer receptors
CA2284103A1 (en) * 1999-09-30 2001-03-30 Edith Bonnelye Estrogen related receptor, err.alpha., a regulator of bone formation
EP1346228A2 (en) * 2000-12-22 2003-09-24 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
JP2004516837A (en) * 2000-12-22 2004-06-10 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Methods for identifying substances that positively affect the inflammatory condition of chronic inflammatory airway disease

Also Published As

Publication number Publication date
MXPA04001128A (en) 2004-05-20
WO2003014745A2 (en) 2003-02-20
CA2453913A1 (en) 2003-02-20
JP2005503787A (en) 2005-02-10
EP1425587A2 (en) 2004-06-09
WO2003014745A3 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2002310044A1 (en) Headwall
AU2002363329A1 (en) Pharmacogenomics-based system for clinical applications
AU2002307768A1 (en) System and method for phytomonitoring
AU2002346242A1 (en) Chromosome doubling method
AU2002331831A1 (en) Compounds and methods for fluorescent labeling
AU2002250858A1 (en) Capsule-in-capsule system and method for the production thereof
AU2002356334A1 (en) Positioning system
AU2001271841A1 (en) Methods for identifying combinations of drugs
AU2002309083A1 (en) Method for identifying drugs for the treatment of type ii diabetes
AU2002333276A1 (en) Drugs for vasculopaties
AU2002345204A1 (en) Method for determining chromatin structure
AU2002341150A1 (en) Method
AU2002250101A1 (en) Lithography method
AU2002310617A1 (en) Inspection system
AU2002345671A1 (en) Post-seal inspection system
AU2002321229A1 (en) Method for identifying anti-inflammatory drugs
AUPR633101A0 (en) Method
AU2002342940A1 (en) New pharmaceutical compounds
AU2002235892A1 (en) Screening method for identifying medicaments
AU2002361450A1 (en) Novel pharmaceutical
AU2002242668A1 (en) Method for rock-chiseling
AU2002362870A1 (en) Method for the provision of location information
AUPR796501A0 (en) Method for identifying tissue types
AU2002100670A4 (en) Database system
AU2002249299A1 (en) Method and means for detecting gluten-induced diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase